Sort
17,828 grants matching “crispr”
Dynamic target recognition and complex assembly of the Type I-E CRISPR-Cas system
$35,616Kaylee E Dillard · University Of Texas At Austin · F31 · FY2019 · GM
Evaluating the impact of obesity-associated inflammation on breast cancer heterogeneity and metastasis using single-cell RNA-seq
$35,564Shannon Bruce McDonell · Univ Of North Carolina Chapel Hill · F30 · FY2019 · CA
Cell-type-specific investigation of the mechanisms underlying neural osmosensation
$35,548Christopher Zimmerman · University Of California, San Francisco · F31 · FY2017 · HL
Defining the persistence associated transcriptome in Chlamydia trachomatis
$35,525Nathan D. Hatch · University Of Nebraska Medical Center · F31 · FY2022 · AI
Investigating the Role of Transcription on DNA Damage at Early Replicating Fragile Sites
$35,518Commodore Perry St Germain · University Of California At Davis · F31 · FY2016 · CA
Characterizing a Serine-Threonine Phosphatase Essential for Asexual Replication in Plasmodium falciparum
$35,516Alexander Aeneas Morano · Harvard Medical School · F31 · FY2023 · AI
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
$35,491Krister Barkovich · University Of California, San Francisco · F30 · FY2016 · CA
The disruption of receptor mediated endocytosis in ethanol teratogenesis
$35,486Timothy Paul Kuka · University Of Texas At Austin · F31 · FY2019 · AA
Investigating the Mechanisms of Resistance to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
$35,424Megan Loree Ludwig · University Of Michigan At Ann Arbor · F31 · FY2017 · CA
Metabotropic contributions to pH-sensitivity and breathing modulation by RTN chemoreceptors
$35,414Elizabeth Catherine Gonye · University Of Virginia · F31 · FY2022 · HL
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
$35,390Erin Elizabeth Hollander · University Of Pennsylvania · F30 · FY2023 · CA
Elucidating the Role of Epithelial PCP signaling in SGN Axon Guidance in the Cochlea
$35,389Shaylyn Clancy · University Of Virginia · F31 · FY2022 · DC
Determining the role of ASCL1 in neuroendocrine prostate cancer
$35,372Kathia E. Rodarte · Ut Southwestern Medical Center · F31 · FY2022 · CA
Development of Small Molecule Inhibitor of PELP1 for Treating Advanced Breast Cancer
$35,256Kristin Ann Altwegg · University Of Texas Hlth Science Center · F31 · FY2021 · CA
âNp53 as a Regulator of p53 Biology
$35,248Cecilia Blair Levandowski · University Of Colorado · F30 · FY2016 · AG
Transcriptional Determinants of L-Asparaginase Response in Leukemia
$35,239Robert Thomas Williams · Weill Medical Coll Of Cornell Univ · F30 · FY2022 · CA
Determining the Microenvironmental Contribution to Acute Myeloid Leukemia Chemoresistance
$35,232Shovik Bandyopadhyay · University Of Pennsylvania · F30 · FY2023 · CA
EGFR T790M-mediated drug resistance in non-small cell lung cancer
$35,225Pinar Ozden Eser · Harvard Medical School · F31 · FY2015 · CA
Identifying targets for combination therapy with FOLFIRINOX and investigating cell polarity loss as a potential driver of invasion in basal-like PDAC
$35,170Sandra Zarmer · Univ Of North Carolina Chapel Hill · F31 · FY2022 · CA
Dissecting the Role of Radiation in Regulation of MHC-I and Neoantigen Presentation
$35,135Chang Su · Duke University · F30 · FY2025 · CA
Mitochondrial mRNA structure as a driver of Leigh Syndrome
$35,135John Conor Moran · University Of Miami School Of Medicine · F30 · FY2025 · HD
Neuronal and homeostatic regulation of sleep and wake by corticotropin-releasing hormone neurons in the paraventricular nucleus of the hypothalamus
$35,133Alyssa N Wiest · University Of Pennsylvania · F31 · FY2023 · HL
Dynamic target recognition and complex assembly of the Type I-E CRISPR-Cas system
$35,124Kaylee E Dillard · University Of Texas At Austin · F31 · FY2018 · GM
Investigating the Role of the C5 complosome in Ethanol-induced Immunometabolic Dysregulation of Kupffer Cells in Alcohol-associated Liver Disease
$35,082Shannon Twardy · University Of Colorado Denver · F31 · FY2025 · AA
beta1 integrin/c-Met: a receptor complex driving invasive resistance to anti-angiogenic therapy in glioblastoma
$35,043Arman Jahangiri · University Of California, San Francisco · F31 · FY2016 · CA